Figure 1.
Patients 1: (a) Alopecia prior to mesalazine; (b) 30 days after mesalazine; (c) relapse after 6 months; (d) end of the treatment
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.